Danforth

Activities: Regulatory Finance

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    The DNA bottleneck: how synthetic manufacturing could unlock the next wave of gene editing therapies As gene-editing therapies evolve towards increasingly complex applications, 4basebio CEO Amy Walker (AW) tells Dr Kevin Robinson (KSR) how advances in scalable enzymatic DNA...
  2. CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates amid DRC outbreak With no licensed vaccines available and more than 900 suspected cases already recorded, CEPI is urgently advancing mRNA, rVSV and viral vector candidates from Moderna, IAVI and...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Why most organisations are failing AI and ISO 42001 audits — and how to fix it Eight in ten executives admit their company wouldn't pass an AI governance audit. With the EU AI Act arriving this August, ISOQAR's information security sector manager, Kirsty...
  4. CordenPharma acquires AmbioPharm to build three-continent peptide API network The deal adds US and Shanghai manufacturing sites to CordenPharma's existing platform, giving pharma customers greater flexibility across SPPS, LPPS and hybrid peptide...
  5. T-CURX acquires Pantherna Therapeutics to fast-track non-viral in vivo CAR-T pipeline Combining transposon-based CAR-T with Pantherna's LNP and mRNA platforms, T-CURX aims to accelerate clinical trials by a year and become Europe's first biotech with both...

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

Related Content

Finance

Danforth Advisors expands to Europe with launch of UK operations
Subscribe now